Search Results

240 results for frx

10 Best “Strong Buy” Stocks — TPL BITA QIHU and more

This week, these ten stocks, all currently earning A’s (“strong buy”) on Portfolio Grader, have the best year-to-date performance.

This New Stock System Could Hand You a 100% Winner by Christmas

Louis Navellier recently shared how he’s working on a project to fuse his legendary Stock Grader system — the same model that’s helped him identify…

This Biotech Bubble Is Bound to Burst

Biotech stocks have been hot thanks to a wave of M&A speculation. That wave, however, has run its course, putting these stocks and biotech ETFs…

Icahn Scores $535 Million — In One Week

Billionaire investor Carl Icahn made a mint on the Google-Motorola merger, but he also earned bank another way. See what he shorted.

NYC Just Sent a Message to Washington – and Wall Street

The 10 Best Stocks in the S&P 500 Through Q2

Energy and technology are well-represented in this list of the S&P 500’s best stocks through 2014’s midway point.

iBillionaire – What Do Hedge Fund Geniuses Like Right Now?

iBillionaire’s latest rebalancing reflects hedge funds’ interest in consumer discretionaries and tech right now.

Amazon’s Outage Wasn’t a Fluke — It Was a Warning

Amazon Web Services (AWS), the cloud arm of Amazon.com Inc. (AMZN), suffered a worldwide outage, affecting more than 1,000 companies and millions of online users.…

Pharmaceutical Companies Hit New Highs, Solar Stocks New Lows

Solar stocks are among the investments hitting new 52 week lows today in the stock market as pharmaceutical companies hit new highs.

7 Fitness Stocks Hoping to Take Peloton’s Crown

With Peloton embroiled in controversy, these fitness stocks look positioned to accelerate their growth in the coming years.

Longtime Vanguard Health Care Manager Owens to Retire

Vanguard announced Wednesday that longtime Vanguard Health Care manager Edward Owens will be stepping down at the end of 2012.

REIT ProLogis (PLD) Opens Lease on New High

2014’s 10 Best Stocks in the S&P 500

Don’t let the S&P 500’s weak 2014 performance fool you — the blue-chip index’s best stocks are a jumpy crowd that cruised 20%-50% in just…

Hertz (HTZ) Gives Carl Icahn 3 Board Seats to Avoid Proxy Battle

Hertz shares rise as the car rental company agrees to give activist investor Carl Icahn 3 board seats.

The Market Rally Resembles a Dog On a Bone

To this point in the year stocks, bonds, gold, oil and gas markets are working just fine, and my charts suggest more to come. Read…

41 S&P 500 Stocks Hit New Lows in Early Tuesday Trading

S&P 500 dips slightly Tuesday, with Urban Outfitters, Abercrombie & Fitch and Citigroup among losers by midday.

Ignore Michael Burry, Stay Invested in Tech

MRK: Merck Sells Consumer Business to Double Down on Blockbusters

Swinging for the fences, MRK sold one of the industry’s crown jewels in exchange for an opportunity to find new blockbuster drugs. It’s a risky…

Is Big Pharma Resistant to Antibiotics?

Less profitable drugs take a backseat despite health risks

Actavis Prescribes Profits via M&A and Generic Drugs

This specialty pharmaceutical company is consolidating its way into becoming a post-Affordable Care Act powerhouse.

No Payday In Sight for Alzheimer’s Drug Stocks

At best, the drugs on the market are stopgap measures. They can’t cure the disease.

Is it Time to Follow Ichan Out of Amgen — and Other Biotechs?

Investor Carl Ichan recently dumped several biotechs. However, Amgen’s sales are strong, and with other positives, it’s possible he cut bait too soon.

Johnson & Johnson, Forest Labs Will Make You Sick

Johnson & Johnson beat expectations but its profits were down; Forest Labs missed and has a plunging profit forecast. Investors should be wary of both…

2 Biotech Stocks to Buy After Earnings

Actavis (ACT) and Jazz Pharmaceuticals (JAZZ) reported outstanding Q3 earnings and are strong biotech stocks to buy.

7 – 10 of 240 results